Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Aug 15, 2019; 11(8): 589-598
Published online Aug 15, 2019. doi: 10.4251/wjgo.v11.i8.589
Published online Aug 15, 2019. doi: 10.4251/wjgo.v11.i8.589
Figure 1 SFRP4 co-expresses with epithelial mesenchymal transition-linked genes in colon cancer.
SFRP4 and the epithelial mesenchymal transition-linked genes have higher expression in samples that are more mesenchymal (red) compared to the more epithelial samples with lower expression (blue).
Figure 2 Epithelial mesenchymal transition-linked genes with positive correlation with SFRP4 expression.
Figure 3 Epithelial mesenchymal transition-linked genes with negative correlation SFRP4 express.
Figure 4 Overall survival of colon cancer patients with low, intermediate or high SFRP4 expression.
A: Patients expressing higher levels of SFRP4 (red line) had poor survival compared to those expressing lower SFRP4 levels (blue line); (B) When a three group analysis was performed, patients with higher SFRP4 expression (red line) presented with poor overall survival compared to patients with intermediate (white lines) or low expression (blue line).
- Citation: Nfonsam LE, Jandova J, Jecius HC, Omesiete PN, Nfonsam VN. SFRP4 expression correlates with epithelial mesenchymal transition-linked genes and poor overall survival in colon cancer patients. World J Gastrointest Oncol 2019; 11(8): 589-598
- URL: https://www.wjgnet.com/1948-5204/full/v11/i8/589.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i8.589